Nucleic acid binding, RNA-binding
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4HSB6
Term | Name | Level | Count |
---|---|---|---|
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0009894 | regulation of catabolic process | 4 | 1 |
GO:0009895 | negative regulation of catabolic process | 5 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010628 | positive regulation of gene expression | 6 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031329 | regulation of cellular catabolic process | 5 | 1 |
GO:0031330 | negative regulation of cellular catabolic process | 6 | 1 |
GO:0043487 | regulation of RNA stability | 3 | 1 |
GO:0043488 | regulation of mRNA stability | 4 | 1 |
GO:0043489 | RNA stabilization | 4 | 1 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0048255 | mRNA stabilization | 5 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051253 | negative regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:1902369 | negative regulation of RNA catabolic process | 7 | 1 |
GO:1902373 | negative regulation of mRNA catabolic process | 7 | 1 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 1 |
GO:1903312 | negative regulation of mRNA metabolic process | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0003729 | mRNA binding | 5 | 1 |
GO:0003730 | mRNA 3'-UTR binding | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 151 | 157 | PF00089 | 0.469 |
CLV_NRD_NRD_1 | 149 | 151 | PF00675 | 0.328 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 238 | 242 | PF00082 | 0.253 |
CLV_PCSK_SKI1_1 | 88 | 92 | PF00082 | 0.196 |
DEG_APCC_DBOX_1 | 168 | 176 | PF00400 | 0.431 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.506 |
DEG_SCF_FBW7_1 | 90 | 95 | PF00400 | 0.396 |
DEG_SPOP_SBC_1 | 298 | 302 | PF00917 | 0.550 |
DOC_CYCLIN_RxL_1 | 166 | 174 | PF00134 | 0.305 |
DOC_MAPK_gen_1 | 149 | 155 | PF00069 | 0.467 |
DOC_PP2B_LxvP_1 | 25 | 28 | PF13499 | 0.525 |
DOC_PP4_FxxP_1 | 138 | 141 | PF00568 | 0.441 |
DOC_PP4_MxPP_1 | 304 | 307 | PF00568 | 0.652 |
DOC_USP7_MATH_1 | 230 | 234 | PF00917 | 0.442 |
DOC_USP7_MATH_1 | 271 | 275 | PF00917 | 0.445 |
DOC_WW_Pin1_4 | 124 | 129 | PF00397 | 0.442 |
DOC_WW_Pin1_4 | 186 | 191 | PF00397 | 0.248 |
DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.577 |
DOC_WW_Pin1_4 | 88 | 93 | PF00397 | 0.400 |
LIG_14-3-3_CanoR_1 | 154 | 161 | PF00244 | 0.428 |
LIG_Clathr_ClatBox_1 | 225 | 229 | PF01394 | 0.396 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.338 |
LIG_FHA_1 | 187 | 193 | PF00498 | 0.361 |
LIG_FHA_1 | 251 | 257 | PF00498 | 0.309 |
LIG_FHA_1 | 270 | 276 | PF00498 | 0.352 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.443 |
LIG_FHA_1 | 89 | 95 | PF00498 | 0.365 |
LIG_FHA_2 | 176 | 182 | PF00498 | 0.321 |
LIG_FHA_2 | 245 | 251 | PF00498 | 0.386 |
LIG_LIR_Apic_2 | 136 | 141 | PF02991 | 0.446 |
LIG_LIR_Gen_1 | 140 | 151 | PF02991 | 0.331 |
LIG_LIR_Gen_1 | 191 | 200 | PF02991 | 0.463 |
LIG_LIR_Gen_1 | 257 | 266 | PF02991 | 0.334 |
LIG_LIR_LC3C_4 | 272 | 277 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 140 | 146 | PF02991 | 0.322 |
LIG_LIR_Nem_3 | 191 | 197 | PF02991 | 0.474 |
LIG_LIR_Nem_3 | 199 | 203 | PF02991 | 0.454 |
LIG_LYPXL_S_1 | 304 | 308 | PF13949 | 0.569 |
LIG_LYPXL_yS_3 | 305 | 308 | PF13949 | 0.543 |
LIG_PTB_Apo_2 | 174 | 181 | PF02174 | 0.314 |
LIG_PTB_Phospho_1 | 174 | 180 | PF10480 | 0.312 |
LIG_REV1ctd_RIR_1 | 135 | 140 | PF16727 | 0.344 |
LIG_SH2_CRK | 12 | 16 | PF00017 | 0.536 |
LIG_SH2_CRK | 39 | 43 | PF00017 | 0.623 |
LIG_SH2_GRB2like | 43 | 46 | PF00017 | 0.593 |
LIG_SH2_NCK_1 | 143 | 147 | PF00017 | 0.326 |
LIG_SH2_NCK_1 | 39 | 43 | PF00017 | 0.623 |
LIG_SH2_SRC | 143 | 146 | PF00017 | 0.314 |
LIG_SH2_SRC | 20 | 23 | PF00017 | 0.583 |
LIG_SH2_SRC | 39 | 42 | PF00017 | 0.567 |
LIG_SH2_SRC | 43 | 46 | PF00017 | 0.537 |
LIG_SH2_STAP1 | 180 | 184 | PF00017 | 0.308 |
LIG_SH2_STAT3 | 2 | 5 | PF00017 | 0.517 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.317 |
LIG_SH3_3 | 16 | 22 | PF00018 | 0.570 |
LIG_SH3_3 | 204 | 210 | PF00018 | 0.396 |
LIG_SUMO_SIM_anti_2 | 204 | 210 | PF11976 | 0.463 |
LIG_SUMO_SIM_anti_2 | 30 | 37 | PF11976 | 0.673 |
LIG_SUMO_SIM_par_1 | 168 | 174 | PF11976 | 0.292 |
LIG_SUMO_SIM_par_1 | 244 | 251 | PF11976 | 0.486 |
LIG_UBA3_1 | 122 | 129 | PF00899 | 0.503 |
MOD_CDK_SPK_2 | 124 | 129 | PF00069 | 0.442 |
MOD_CK1_1 | 127 | 133 | PF00069 | 0.407 |
MOD_CK1_1 | 199 | 205 | PF00069 | 0.457 |
MOD_CK2_1 | 244 | 250 | PF00069 | 0.544 |
MOD_Cter_Amidation | 147 | 150 | PF01082 | 0.357 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.196 |
MOD_GlcNHglycan | 181 | 185 | PF01048 | 0.375 |
MOD_GlcNHglycan | 232 | 235 | PF01048 | 0.298 |
MOD_GSK3_1 | 161 | 168 | PF00069 | 0.393 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.292 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.607 |
MOD_GSK3_1 | 244 | 251 | PF00069 | 0.494 |
MOD_GSK3_1 | 265 | 272 | PF00069 | 0.462 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.396 |
MOD_N-GLC_1 | 159 | 164 | PF02516 | 0.469 |
MOD_N-GLC_1 | 211 | 216 | PF02516 | 0.196 |
MOD_N-GLC_1 | 79 | 84 | PF02516 | 0.462 |
MOD_N-GLC_1 | 88 | 93 | PF02516 | 0.166 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.405 |
MOD_NEK2_1 | 171 | 176 | PF00069 | 0.280 |
MOD_NEK2_1 | 248 | 253 | PF00069 | 0.474 |
MOD_NEK2_1 | 299 | 304 | PF00069 | 0.573 |
MOD_PIKK_1 | 161 | 167 | PF00454 | 0.393 |
MOD_PIKK_1 | 175 | 181 | PF00454 | 0.320 |
MOD_PIKK_1 | 212 | 218 | PF00454 | 0.420 |
MOD_PIKK_1 | 66 | 72 | PF00454 | 0.720 |
MOD_PIKK_1 | 92 | 98 | PF00454 | 0.396 |
MOD_PKA_2 | 153 | 159 | PF00069 | 0.435 |
MOD_PKA_2 | 230 | 236 | PF00069 | 0.500 |
MOD_Plk_1 | 212 | 218 | PF00069 | 0.500 |
MOD_Plk_1 | 79 | 85 | PF00069 | 0.407 |
MOD_Plk_1 | 92 | 98 | PF00069 | 0.381 |
MOD_Plk_4 | 171 | 177 | PF00069 | 0.323 |
MOD_Plk_4 | 271 | 277 | PF00069 | 0.443 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.656 |
MOD_Plk_4 | 80 | 86 | PF00069 | 0.597 |
MOD_ProDKin_1 | 124 | 130 | PF00069 | 0.442 |
MOD_ProDKin_1 | 186 | 192 | PF00069 | 0.248 |
MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.577 |
MOD_ProDKin_1 | 88 | 94 | PF00069 | 0.400 |
MOD_SUMO_for_1 | 210 | 213 | PF00179 | 0.407 |
MOD_SUMO_rev_2 | 261 | 269 | PF00179 | 0.382 |
TRG_ENDOCYTIC_2 | 143 | 146 | PF00928 | 0.306 |
TRG_ENDOCYTIC_2 | 152 | 155 | PF00928 | 0.307 |
TRG_ENDOCYTIC_2 | 194 | 197 | PF00928 | 0.430 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.430 |
TRG_ENDOCYTIC_2 | 305 | 308 | PF00928 | 0.543 |
TRG_ER_diArg_1 | 149 | 151 | PF00400 | 0.328 |
TRG_ER_diArg_1 | 71 | 74 | PF00400 | 0.595 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I013 | Leptomonas seymouri | 76% | 96% |
A0A0S4JUP2 | Bodo saltans | 68% | 77% |
A0A1X0NMJ6 | Trypanosomatidae | 67% | 98% |
A0A3R7NIY6 | Trypanosoma rangeli | 66% | 97% |
A0A3S7WNY0 | Leishmania donovani | 100% | 100% |
A4H432 | Leishmania braziliensis | 95% | 100% |
C9ZYA9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 68% | 95% |
E9AK98 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
O97003 | Leishmania major | 99% | 100% |
V5BDL5 | Trypanosoma cruzi | 65% | 99% |